Descriptive studies have suggested that the Affordable Care Act's (ACA) health insurance Marketplaces improved access to care. However, no quasi-experimental evidence is currently available to support these findings. We use longitudinal survey data to compare previouslyuninsured adults to adults who had employer-sponsored insurance (ESI) prior to the ACA, in the income range eligible for subsidized Marketplace coverage (138-400% of poverty). Among the previously-uninsured group, the ACA led to a significant decline in the uninsurance rate (-10.8 percentage points), decreased barriers to medical care, increased use of outpatient services and prescriptions drugs, and increased identification of high blood pressure, compared to a control group with stable ESI. Changes were largest among those with incomes between 138-250% of poverty, who were eligible for the ACA's cost-sharing reductions. Our quasi-experimental approach provides rigorous new evidence that the ACA's Marketplaces led to improvements in several important health care outcomes, particularly among lower-income adults.
INTRODUCTION
Evidence on the effects of the Affordable Care Act (ACA) continues to grow, even as the likely elimination of the individual mandate penalty and ongoing political debate has made its future impact uncertain. Numerous studies have examined impacts of the Medicaid expansion, (1) (2) (3) whereas less research has focused on the ACA's health insurance Marketplaces.
The Marketplaces offer subsidized coverage to families with incomes between 138-400% of poverty (100-400% in states that did not expand Medicaid), and provide cost-sharing reductions for those with incomes below 250%. 6.7 million people purchased insurance through ACA Marketplaces in the first open enrollment period spanning from October of 2013 to March of 2014,(4) and 10.3 million had done so by 2017.(5) One study estimated that subsidized Marketplace coverage accounted for 40% of the ACA's reduction in the uninsured rate. (6) The Marketplaces were designed to improve affordability and accessibility of health care for low-and middle-income populations. In addition to premium and cost-sharing subsidies, the ACA also abolished annual and lifetime limits, mandated that insurance plans cover a set of "essential health benefits," and outlawed pre-existing condition exclusions.(7) Observational studies have shown substantial increases in coverage among those eligible for Marketplace subsidies, (8) (9) (10) increased likelihood of having a usual source of care and access to medications, (11) and increased rates of blood pressure screening. (12, 13) However, to our knowledge, there has been no quasi-experimental evidence on the Marketplaces' impact.
Rigorous evaluations of changes in coverage and access in the Marketplace-eligible income range are needed, particularly because higher cost-sharing requirements (14) and narrow networks in Marketplace plans (15) may limit the generalizability of evidence from the ACA's Medicaid expansion. Finally, observational analyses of people gaining Marketplace coverage that do not include a control group run the risk of multiple forms of bias -including secular trends in health outcomes, the economic recovery, and selective enrollment among a subset of eligible applicants.
Our study assessed the impact of newly-available Marketplace coverage on previouslyuninsured non-elderly adults who became eligible for subsidized Marketplace plans in 2014.
Using longitudinal survey data, we performed a difference-in-differences analysis comparing health and spending outcomes among those who were uninsured prior the ACA to a cohort of adults with stable employer-sponsored insurance in the income range eligible for subsidized Marketplace coverage.
METHODS

Data:
We analyzed data from the nationally-representative Medical Expenditure Panel Survey (MEPS). Data is collected for each member of surveyed households over a two-year period and is available in two-year, longitudinal datasets (for simplicity, we refer below to the first and second years of data as Year 1 and Year 2 for each observation). (16) We used three longitudinal data sets: 2011-2012; 2012-2013; and 2013-2014 (Appendix A). We began our study period in 2011 since earlier datasets would be potentially subject to changes related to the Great Recession, as well as the immediate effects of the ACA's dependent coverage provision, which took effect beginning in 2010. The 2013-2014 data set captures the implementation of major ACA policies on January 1, 2014. The 2013-2014 panel was the cohort in which the intervention took place, the "ACA-affected cohort," while the panels from 2011-2012 and 2012-2013 were combined to form a pre-ACA cohort.
Study Design and Sample:
Our study used a difference-in-differences analysis, measuring changes in health insurance coverage, access to care, utilization, and costs before and after 2014 in an intervention group compared to a control group.
Our intervention group was comprised of adults aged 18-63 with Year 1 family incomes between 138 and 400% of the Federal Poverty Level (FPL), who were uninsured for 6 months or more in Year 1. Family income was defined based on concept of the health-insurance unit (an adult, his/her spouse, and any dependent children). Most individuals in this group (subject to the limitations discussed below) became eligible to purchase premium-subsidized insurance on state health insurance Marketplaces in 2014, and those with incomes below 250% also qualified for cost-sharing reductions. We chose six months of uninsurance as our cut-off to capture the longer-term uninsured population, as opposed to individuals who had brief gaps in coverage due to job changes or temporary fluctuations in income.
The control group consisted of non-elderly adults with incomes between 138-400% of poverty who were insured with employer-sponsored insurance (ESI) for all twelve months of Year 1. Although there is no perfect control group for the creation of the ACA Marketplaces, previous research demonstrates that the ACA had little detectable effects on ESI, indicating that this group was largely insulated from changes affecting our treatment group,(17-19) making it a useful comparator to account for potential secular trends in the economy and the health care system.
Outcome Variables:
Our sample was defined based on Year 1 features (age, income, and insurance status).
All outcome measures were drawn from Year 2 of the datasets.
Our primary coverage outcome was health insurance status as of the last month of Year 2.
Insurance type is self-reported in the MEPS. Categories of insurance included private employersponsored insurance; non-group private insurance (including Marketplace coverage); Medicaid; and uninsured. As a secondary outcome, we also measured the total number of insured months in 
Statistical Analysis:
We used linear regression models for both binary and non-binary outcomes for ease of interpretation.(24) Our models adjusted for key demographic characteristics and economic indicators (all from Year 1) including age, sex, race, region, marital status, family size, birthplace outside the U.S., family income, and employment status. All models included two binary indicators: previously-uninsured (intervention) vs. previously-insured via stable ESI (control) group; and pre-vs. post-ACA cohort. The interaction term between these two variables yielded our difference-in-difference estimate.
In a subgroup analysis, we divided our study population by income: a low-income group (family income 138-250% of poverty), which was eligible for both premium subsidies and costsharing reductions through Marketplace plans, and a middle-income group (251-400% of poverty), eligible only for premium-cost assistance.
Our primary analysis defined income based on the health insurance unit, but we also conducted a sensitivity analysis using the less-restrictive MEPS definition for family income.(21)
We tested for diverging trends prior to 2014 for our treatment and control group. This analysis used a placebo difference-in-difference model as if the ACA had been implemented in 2013, (25) comparing study outcomes between the previously-uninsured group and the stable-ESI group in the 2011-2012 vs. the 2012-2013 panel.
All regressions were performed with SAS (Version 9.4) using survey-based procedures that accounted for the complex sample design and weights in the MEPS.
Limitations:
Our study was subject to several limitations. This study includes only a single year of post-ACA data and therefore captures only the first-year effects of the Marketplaces. The ACA's effects would be expected to increase after the first year given that enrollment continued to rise(26) and recipients would have more time to take advantage of newly-acquired benefits.
Changes in some outcomes, especially self-reported health status, may not apparent in the first
year. (27) The use of only a single post-ACA year was unavoidable given our study design, which relied on two-year longitudinal data from MEPS and specifically exploited the single cohort that overlapped the launch of the ACA's major policies. We feel that this tradeoff is worthwhile given the strength of our study design compared to prior Marketplace-specific analyses.
Although the MEPS is a relatively large dataset, our inclusion criteria resulted in smaller study sample. This may have limited our power to detect small changes that may be clinically or economically relevant, and also precluded analyzing outcomes that were relevant only to a small subset of our sample, such as mammography or pap smear rates. Additionally, following the majority of studies in the coverage expansion literature (3, 28-31), we did not adjust for multiple comparisons, which may increase the risk of false positives.
The MEPS does not include state identifiers in publicly available files. This prevented us from examining the effects of state-specific programs such as the use of insurance navigators and the impact of state-vs. federally-administered Marketplaces, although this may have been challenging given sample-size limitations. In at least one study, state-administered Marketplaces were shown to be more effective in expanding coverage.(6) Lack of state identifiers also eliminated the possibility of controlling for the effect of Medicaid expansion in some states, which affects the income-range in each state eligible for Marketplace coverage.
In addition, not all uninsured adults may have been eligible for Marketplace subsidies, either due to immigration status or having an affordable offer of ESI that they did not accept.
Our dataset did not allow us to evaluate these factors; if anything, this would lead our analysis to underestimate the changes in coverage and access among the truly eligible population.
Finally, as stated earlier, no perfect control group exists for the ACA's Marketplace, given that this policy was implemented on a national level at a single point in time. Many observed differences exist between our intervention and control groups, as well as potentially unobservable differences. However, the validity of our difference-in-difference study design does not depend on the balance of characteristics between the study groups, but rather on the assumption that trends would have been comparable for both study groups in the absence of the policy change. The placebo tests of the pre-ACA period provide support for this assumption.
The use of our control group strengthens the analysis by reducing bias from mean reversion and secular trends in our estimates of Marketplace effects on the previously-uninsured.
RESULTS
Our study population included 9,653 adults. 5,770 had continuous coverage with ESI and 3,883 were uninsured for six months or more in Year 1 (Exhibit 1). Compared to the stable ESI group (control group), the uninsured group (treatment group) was younger and more likely to be male, Hispanic, and live in the South or West. Mean family income was lower in the treatment group, which was also somewhat less likely to be employed prior to the ACA -though the majority of adults in both groups were employed (82.7% vs. 86.9%).
Exhibit 2 presents changes in health insurance before and after the ACA for each study group. Among the treatment group compared to the control group, ACA implementation was associated with a large drop in the uninsured rate by the end of Year 2 (-10.8 percentage points, p<0.001). The likelihood of having any private insurance increased by 8.8 percentage points (p<0.001). More specifically, rates of non-group private coverage (including Marketplace plans) increased by 6.0 percentage points (p<0.001), while Medicaid participation increased to a lesser degree (2.5%, p=0.06) and ESI enrollment did not increase significantly. In 2014, Marketplace coverage rates were 6.8% in the treatment group and 1.1% in the control group.
Exhibit 3 shows monthly rates of non-group private coverage for the treatment and control groups -which demonstrates a sharp rise for the treatment group in the first three months of 2014, while the control group remained relatively constant.
Regression-based difference-in-difference estimates are presented in Exhibit 4, and Appendix C presents plots of several outcomes over time for the treatment vs. control group.
The share of previously-uninsured adults reporting that they were unable to get necessary care declined by 1.9 percentage points compared to the control group (p=0.08). There were no significant changes in the probability of delaying prescription medications or having a usual source of care. Among those with any expenditures, total medical spending increased by 14.3% and out-of-pocket spending increased by 9.7%, but neither estimate reached statistical significance.
The average number of outpatient visits increased by 0.87 (p=0.08) among the previously-uninsured, compared to the control group. The probability of inpatient admission increased by 2.5 percentage points (p=0.04). The number of prescriptions filled increased by 1.82 medications on average (p=0.05). The likelihood of emergency department visits did not change significantly, and neither did preventive visits or self-reported health. The likelihood of receiving a diagnosis of hypertension increased by 7 percentage points among the previously uninsured (p=0.003).
Results of a sensitivity analysis using a broader family definition to measure income yielded similar results to our primary analysis (Appendix D). In comparison, the number of previously-uninsured adults reporting that they were unable to get necessary care showed a larger decline (-2.4 percentage points, p=0.03) and the number of outpatient visits increased more robustly (1.31 additional visits, p=0.03).
Subgroup analysis:
Both the low-income group (138-250% FPL) and the middle-income group (250-400% FPL) experienced large increases in coverage by the end of Year 2 (11.1% and 13.2% respectively, both p<0.01; Exhibit 4).
Changes in access and utilization were generally larger among the lower-income subgroup than the higher-income subgroup (Exhibit 4), though with some variation across outcomes. For the lower-income group, rates of being unable to access care declined significantly (-2.7 percentage points, p=0.05) and outpatient utilization increased (1.96 visits, p=0.004), compared to the control group. Likelihood of any inpatient admission rose by 3.8 percentage points (p=0.07). The low-income subgroup also showed a large increase in the number of prescription fills (an additional 4.62 per year, p=0.001) and in the likelihood of hypertension diagnosis (+6.1 percentage points, p=0.06). Diagnosis of high cholesterol showed an increase in the low-income subgroup (5.7 percentage points, p=0.06), which was not evident in the full sample.
In the higher-income subgroup, previously uninsured adults experienced a decreased likelihood of delaying medications (-3.3 percentage points, p=0.03) and increased likelihood of hypertension diagnosis (7.7 percentage points, p=0.08). Total medical spending among those with any expenditures also rose in this subgroup (38.3%, p=0.05).
Placebo tests:
Our placebo analysis showed no significant differential changes in the pre-ACA cohort for nearly all study outcomes (Appendix B). Only one outcome -cholesterol screeningshowed a difference at p<0.10; however, this indicated that the likelihood of screening was decreasing in the pre-ACA period for our treatment group, which would bias us against finding a positive result in this group. Overall, these findings demonstrate comparable pre-ACA trends in outcomes for our treatment and control groups, supporting our difference-in-difference approach.
DISCUSSION
Using a rich longitudinal national survey, our study offers new evidence on the effect of the ACA's health insurance Marketplaces on subsidy-eligible adults. Insurance coverage increased significantly among previously-uninsured adults, with the majority of growth due to Marketplace coverage. These coverage gains were accompanied by a reduction in barriers to needed care, more outpatient visits, increased inpatient care, and additional use of prescription drugs. We also find an increase in the rates of diagnosis of hypertension. Other outcomes, including out-of-pocket and total spending, did not change. Our findings, detected in the first year after the ACA's implementation, suggest that the Marketplaces are contributing to a broad range of positive effects for previously-uninsured adults. Our analysis of income subgroups suggests that improvements in access to care were concentrated among lower-income adults eligible for cost-sharing subsidies.
These results demonstrate that, despite initial challenges in the rollout of the Marketplace, the program was successful in improving coverage among many long-term uninsured adults.
However, even after the expansion, more than half of this group remained uninsured at the end of 2014, indicating significant outreach efforts are still needed. Of course, our use of a dataset ending in 2014 means that longer-term gains in coverage are not captured in our results. Of note, only 1% of the control group was found to have purchased insurance through the Marketplace in 2014, indicating that crowd-out of employer-sponsored insurance by the new Marketplace subsidies was rare, consistent with prior studies of the ACA. (6, 19) Our findings of coverage changes are supported by several observational studies that have documented similarly-sized changes in the uninsured rate using the National Health Interview Survey,(9) Health Reform Monitoring Survey,(32) American Community Survey, (6) and Gallup-Healthways Well-Being Index. (33) We also identified several significant changes in access to care and utilization after coverage expansion, consistent with studies of Medicaid expansion under the ACA. This suggests that despite concerns over potentially high cost-sharing and narrow networks in the ACA,(34) , (15) subsidized Marketplace coverage has still improved care for many middle-income adults. Of note, increases in ESI and Medicaid coverage accounted for just under half of the coverage gains in our previously-uninsured group, indicating that our findings are not solely attributable to new Marketplace coverage. Still, our results are consistent with several observational studies of those in the subsidized Marketplace income range or those who report enrolling in Marketplace plans. (13, 30, 35) To our knowledge, no previous work has used quasi-experimental methods to examine changes in health care outcomes among a population of previously uninsured Marketplacesubsidy-eligible adults. Examining longer-term trends in coverage and other health outcomes among these individuals is an area for future research.
Despite finding some beneficial changes in access to care and chronic disease diagnosis, many of our study outcomes -including total spending, preventive health measures, and selfreported health -did not change significantly, in contrast to prior studies of the Medicaid expansion.(1-3) This may reflect the relatively small sample size and that the study only included the first year after ACA implementation; many of those who obtained new insurance in 2014 began coverage midway through the year, leaving limited time to take advantage of new opportunities to seek care. However, it is also possible that Marketplace coverage may be less effective at improving some of these measures than Medicaid, and at least some descriptive evidence suggests that concerns exist about these plans' cost-sharing requirements. For instance, a Kaiser Family Foundation survey found that 36% of Marketplace enrollees were somewhat or very dissatisfied with the burden of their insurance deductible compared with 25% of those with ESI coverage.(36) While our study shows this coverage has been beneficial, our post-ACA estimates show that many adults still experience barriers to care, and cost-related challenges may be more common in Marketplace plans with high cost-sharing than in Medicaid, which traditionally has only minimal out-of-pocket payments. (37) Our subgroup analysis revealed that improvements in access to care was generally larger in the lower-income (138-250% of poverty) subgroup. This has important implications for the ACA's cost-sharing reductions, which are available to Marketplace enrollees with incomes below 250% of FPL. Insurers are required to reduce out-of-pocket costs for this group and receive payments from the federal government for these expenses; however, the Trump Administration has announced a decision to stop making these payments. (38) Our findings suggest that these cost-sharing subsidies may be an important driver of the positive impacts of Marketplace coverage. However, cost-sharing subsidies are only one potential explanation for the larger effect found in the low-income subgroup. Another is simply that this group had more unmet medical needs prior to the ACA.
Conclusions
Our study provides some of the first quasi-experimental evidence on the effects of the ACA's Marketplace plans on middle and lower-income nonelderly adults who previously lacked insurance. We identified several notable improvements among previously-uninsured adults in terms of health care access and utilization. These benefits were larger for lower-income adults eligible to receive cost-sharing reductions. The Trump Administration's decision to cease payments for cost-sharing subsidies to insurers, as well as plans to eliminate the individual mandate, could further erode Marketplace coverage and could undo some of these gains. However, despite notable improvements, we also find that many barriers to care remain in this population. Legislative changes to Marketplace plans that increase generosity of subsidies and boost enrollment might produce greater progress on a range of health-care related outcomes. insurance for 12 months in year one of the dataset. The previously-uninsured group was uninsured for > or = 6 months in year one of the dataset. The Pre-ACA cohort includes the 2011-2012 and 2012-2013 panels. The ACA-affected cohort includes the 2013-2014 panel. For spending figures, we took logarithms of dollar amounts to normalize the skewed distribution of spending and added one dollar to the measures of total and out-of-pocket spending (prior to log-transformation) so that those with zero spending would remain part the analysis. *p<0.1, **p<0.05, ***p<0.01, ****p<0.001
